| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.0058 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |